Eric Kuhlman, DPM
Foot & Ankle Surgery · Thornton, CONPI 1003170333
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), consulting fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Musculoskeletal Transplant Foundation Inc. accounts for 62.8% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2020 at $10,161 and has fallen 74.6% since, to $2,585 in 2025.
Across 147 payments — averaging $144.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$13K
- Vilex LLC$2K
- Stryker$2K
- Integra Lifesciences Corporation$713
- Treace Medical Concepts, Inc.$439
- Zimmer Biomet$404
- plus $2K from 30 others
Across 19 payments — averaging $4270.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Polarityte, Inc.$66K
- Ipsen Innovation$16K
What the payments were for
- Royalty or licence$2,27311%
- Consulting fees$6,37530%
- Travel & lodging$1,3176%
- Food & beverage$11,34953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 34 | $13,394 |
| Vilex LLC | 3 | $2,369 |
| Stryker(2 entities) | 17 | $1,887 |
| Integra Lifesciences Corporation | 17 | $713 |
| Treace Medical Concepts, Inc. | 5 | $439 |
| Zimmer Biomet | 6 | $404 |
| Organogenesis Inc. | 3 | $300 |
| Sanara Medtech Inc. | 1 | $248 |
| Smith+Nephew | 10 | $212 |
| KCI USA, Inc. | 3 | $208 |
| Johnson & Johnson | 5 | $133 |
| Tactile Systems Technology Inc | 1 | $116 |
| Nevro Corp. | 1 | $87 |
| Amgen(2 entities) | 5 | $84 |
| Kerecis Limited | 3 | $78 |
| Bioventus LLC | 4 | $77 |
| GRT US Holding, Inc. | 4 | $66 |
| AbbVie | 3 | $58 |
| Acumed LLC | 2 | $54 |
| Medline Industries LP | 2 | $48 |
| Orthofix Medical, Inc. | 3 | $40 |
| Illuminoss Medical, Inc. | 1 | $39 |
| Gemini Mountain Medical, LLC | 1 | $36 |
| Exactech, Inc. | 1 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| Reddress USA, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Lifenet Health | 1 | $15 |
| Innovation Technologies Inc | 1 | $15 |
| Biocomposites Inc | 1 | $15 |
| Reprise Biomedical, Inc. | 1 | $15 |
| Biotissue Holdings Inc. | 1 | $14 |
| Acell, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
| Osteoremedies, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTIX$2,273
- HOFFMANN$300
- Lapiplasty System$277
- INTEGRA WOUND MATRIX (IWM)$272
- CellerateRx$248
- PRIME SERIES$233
- AXSOS$185
- Stratum Foot Plating System$153
- PuraPly$151
- BILAYER WOUND MATRIX (BWM)$137
- AMNIOEXCEL$137
- IDRT$137
- FLOWABLE$137
- INTEGRA MESHED BILAYER WOUND MATRIX$135
- PRIMATRIX$135
- INTEGRA DERMAL REGENERATION TEMPLATE$135
- INTEGRA FLOWABLE WOUND MATRIX$135
- Puraply, NuShield, Affinity$130
- VAC VERAFLO$123
- VAC VERAFLO CLEANSE CHOICE$123
How this compares
$21,314 in reported general payments places this provider in the 85th percentile of 181 foot & ankle surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 40 | $829 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $680 |
| Ondansetron OdtOndansetron | 36 | $457 |
| Oxycodone Hcl | 50 | $428 |
| Terbinafine Hcl | 30 | $405 |
| Doxycycline Hyclate | 21 | $314 |
| Gabapentin | 49 | $276 |
| Clindamycin Hcl | 21 | $240 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $234 |
| Cephalexin | 29 | $214 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Thornton
- Michael HoughtonFort Collins$2M
- Joshua MetzlEnglewood$1.8M
- Brad DresherColorado Springs$1.3M
- Thomas ClantonVail$1.1M
- Brett SachsWheat Ridge$806K
- Jeffrey LehrmanFort Collins$628K
- Kevin NagamaniDenver$288K
- Keith JacobsonDenver$241K
- William MontrossColorado Springs$238K
- Dustin KruseWheat Ridge$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.